Pharming Group N.V. Profit Margin

The latest profit margin for PHAR is 2.41% as of June 2026. That compares with -2.41% in the prior-year period — up 199.9% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Pharming Group N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PHAR's profit margin moved from -2.41% to 2.41% — a 199.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pharming Group N.V.'s valuation or profitability profile.

Against Healthcare companies, PHAR currently prints 2.41% for profit margin, while the sector average sits near 13.89%. That is roughly 82.6% below the sector mean. Large gaps often invite a closer look at Pharming Group N.V.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Pharming Group N.V. converts resources into returns. At 2.41%, PHAR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2.41% in the prior-year period — up 199.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PHAR's profit margin (2.41%), review year-over-year change from -2.41%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.